OBJECTIVE: To investigate whether the region of chromosome 11 (11q13) containing the genes UCP2 and UCP3 could be excluded for linkage with a variety of obesity-related phenotypes in humans. DESIGN: Exclusion mapping using a variance component approach in extended pedigrees. SUBJECTS: Four-hundred and ®fty eight individuals (195 females, 263 males) distributed in 10 Mexican American families of probands randomly ascertained with respect to any disease state and who are participating in the San Antonio Family Heart Study. Ages range from 18 to 87 (mean age 35 y). MEASUREMENTS: Serum leptin levels, fat mass (FM), body mass index (BMI), and waist circumference. RESULTS: We were able to exclude the chromosomal region containing UCP2aUCP3 as having an effect on this set of obesity-related phenotypes at relative effect sizes of 10% or greater (P-values`0.05). CONCLUSIONS: These results suggest that variation in these genes is unlikely to have a substantial effect on the expression of obesity-related phenotypes in the Mexican American population.
Introduction
Uncoupling proteins (UCPs) function in the regulation of energy expenditure, and may be implicated in the development of obesity. 1 While UCP1 is expressed in brown adipose tissue 2 , the two recently discovered proteins UCP2 and UCP3 are expressed either in a wide variety of tissues (UCP2) including white adipose tissue and skeletal muscle 3, 4 or in muscle tissue (UCP3). 5, 6 The structural genes coding for these two proteins (UCP2 and UCP3) are both located on chromosome 11 (11q13) and are separated by approximately 7 kb. 7 Both of these genes have been proposed as candidate genes for human obesity based on their perceived role in the regulation of energy expenditure. 1 However, in a previous multipoint genome scan, utilizing a 15 cM map, we failed to detect any evidence of linkage between the region of chromosome 11 containing UCP2aUCP3 and obesity-related phenotypes. 8 In contrast, Bouchard and colleagues 9 have reported linkage between markers¯anking UCP2 and UCP3 and resting metabolic rate (RMR), but this was limited to a two-point linkage analysis. A number of variants in coding and non-coding regions of UCP2 and UCP3 have been described and association studies performed. Pima Indians heterozygous for an Ala?Val substitution in exon 4 and a 45 bp insertiona deletion in the 3 0 -untranslated region of exon 8 of UCP2 had increased metabolic rates during sleep when compared to Ala ± Ala homozygotes. 10 African American subjects heterozygous for an exon 6 splice junction polymorphism had markedly reduced fat oxidation and high respiratory quotients. 11 Prior work in the Pima Indian population had detected suggestive evidence of linkage (LODS 2.1) for percentage body fat and 24 h energy expenditure on chromosome 11 in the region of 11q21 ± q24. 12 However, UCP2aUCP3 maps to 11q13, 7 which is approximately 15 cM from 11q21 ± 24 making UCP2aUCP3 contribution to the observed linkage signal questionable. As part of our continuing genome screening initiative in the San Antonio Family Heart Study (SAFHS), we have now typed a polymorphism in the immediate vicinity of UCP2aUCP3 and have included this marker in our linkage screening set. Given the contradictory nature of the published results concerning the relationship between variation in the vicinity of UCP2aUCP3 and obesity-related phenotypes, we speci®cally tested for formal exclusion of linkage in the context of a quantitative trait locus (QTL) analysis using extended pedigree data in Mexican Americans.
Materials and methods

The population
Subjects in this study included 458 individuals (195 females, 263 males) distributed in 10 Mexican American families and ranging in age from 18 to 87 y (mean age 35 y). These families are all participants in the San Antonio Family Heart Study, a broader project designed to investigate the genetics of risk factors for atherosclerosis, non-insulin dependant diabetes mellitus (NIDDM) and obesity. 13, 14 Probands and family members for this analysis were ascertained without regard to obesity or any other pre-existing medical conditions. However, on the basis of the most recent criteria, 15 72% of these SAFHS participants would be classi®ed as overweight (body mass index (BMI) b25 kgam 2 )) and 38% would be classi®ed as obese (BMI 30 kgam 2 ). Although Mexican Americans constitute an admixed population, the degree of admixture and inter-individual variation in admixture is predominantly a function of socio-economic status with low-income individuals exhibiting higher levels of Amerind admixture. 16 We limited the study population to low-income families to minimize genetic heterogeneity due to differential admixture. All protocols were approved by the Institutional Review Board at the University of Texas Health Science Center, San Antonio, Texas.
The phenotype
We measured leptin levels by radioimmunoassay (RIA) in serum samples collected following an overnight (approximately 12 h) fast. The assay was conducted using a commercially available RIA kit (Linco, St Louis, MO). 17 The inter-assay coef®cient of variation (CV) for this assay was 7.4%, a value within the range reported by the manufacturer. 17 In addition, we included three other quantitative measures of body fat accumulation, fat mass (FM), BMI, and waist circumference. FM was obtained by bioimpedance 18 and expressed as kilograms of fat. BMI and waist circumferences were collected following standardized protocols for the collection of anthropometric measures. Descriptive statistics for the distribution of these traits in this sample are given in Table 1 .
Genotyping
For these analyses we supplemented our existing 15 cM map for chromosome 11 8 by typing an additional microsatellite marker, D11S916, which maps just adjacent to the UCP2aUCP3 loci at 11q13. We used lymphocyte DNA samples for PCR with thē uorescently labeled primer from Research Genetics Inc., according to their protocol.
Statistical Analysis
We ®rst mapped the position of D11S916 relative to the other markers we had already typed for chromosome 11 using CRI-MAP. 19 Following the mapping of D11S916, we then performed both two-point and multipoint variance component linkage analyses implemented in the program package SOLAR. 20 In all of the analyses the effects of age and sex were simultaneously estimated. In the case of the two-point linkage analyses we compared a series of models with ®xed quantitative trait locus (QTL) effect sizes accounting for 10 ± 40% of the total phenotypic variance with a model allowing for no QTL effect at UCP2aUCP3 (represented by D11S916). The choice of 10% as the lower bound for effects represents the reliable limits of detection given the current sample size. With regard to the multipoint linkage analyses we compared a series of models with ®xed QTL effect sizes with a model allowing for no QTL effect evaluated at 2 cM intervals across chromosome 11. This approach avoids confusing a failure to detect linkage with the actual exclusion of linkage by allowing for the explicit test of linkage. The comparison of the competing models was done by means of the likelihood ratio test that yields a test statistic asymptotically distributed as a w 2 with degrees of freedom equal to the difference in the number of independent parameters being estimated in the two models. Since we are testing a very speci®c point hypothesis then a P-value 0.05 (which corresponds to a LOD score 0.588) is suf®cient to exclude linkage.
Results
We were able to map D11S916 to 88.1 cM from p-ter on chromosome 11, placing it between UCP2 and UCP3 (approximately 5 kb from UCP3). Using twopoint linkage analysis we tested a series of speci®c hypotheses concerning varying QTL effect sizes at D11S916. For all four obesity-related phenotypes we were able to exclude evidence of linkage with D11S196 at effect sizes of 10% or greater (P- Figure 1 graphically represents the rate of decay in the LOD scores at D11S916 for QTL effect sizes ranging from 10% to 40% for all four phenotypes. Next we utilized a multipoint linkage analysis to test for evidence of a QTL of various effect sizes across all of chromosome 11. The multipoint analyses of all four of the phenotypes yielded results similar to those from the two-point analyses, producing negative LOD scores across the whole of chromosome 11 for QTLs with effect sizes of 10% or greater. The LOD functions for the multipoint analyses for leptin and fat mass are shown in Figures 2  and 3 , respectively. Similar patterns were obtained for BMI and waist circumference (data not shown).
Discussion
The discovery of new uncoupling proteins (ie UCP2 and UCP3) that appear to be expressed in adipose tissue and muscle offers exciting possibilities for furthering our understanding of the causes of obesity. While these proteins may indeed play a fundamental role in the regulation of total body fat via control of energy expenditure, it remains questionable whether variation in either UCP2 or UCP3 has any substantial effect on the variation in obesity-related phenotypes at a population level. No published genome scans to date have reported evidence of signi®cant linkage of obesity-related phenotypes and a QTL at 11q13, 8, 12, 21, 22 and the one published positive candidate gene linkage for this region with resting metabolic rate offers no estimate of the relative effect size for UCP2aUCP3.
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In contrast, the results of our exclusion analyses show that genetic variation in the region of chromosome 11 containing UCP2aUCP3 is unlikely to have a substantial effect (ie b10%) on the expression of obesity-related phenotypes in this sample of Mexican Americans. That is not to say that these genes may not have minor effects (ie b10%) and that in combination with other genes may produce detectable effects, however, such detection would require samples of much larger sizes than are currently available. These ®ndings should not be interpreted as diminishing the interest in the uncoupling proteins as potential regulators of adipose tissue mass, but rather do suggest that variation in their structural genes (ie UCP2 and UCP3) may have only limited effects on the variation of body fat at the population level. Indeed, we would suggest that effort should be focused on the search for the genes that regulate the expression of these potentially very important proteins. Linkage exclusion analysis of UCP2 and UCP3 AG Comuzzie et al
